PLOD1 and polycystic ovary syndrome: Also, Prelevic et al showed that the compounds of L-DOPA and bromocriptin (dopamine agonist) in PCOS patients with hyperprolactinemia can cause a significant decrease in LH levels in comparison to the normoprolacinemia group (32).